InsidersTradesSigma
Discover the complete record of transactions filed by Oram Jeffrey, Director. Officer active across 1 companies, notably Alzamend Neuro, Inc.. Aggregated, 5 disclosures have been logged. The latest transaction was filed on 15 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Oram Jeffrey is a Board Member of Alzamend Neuro, Inc. In this role, he participates in the governance of the company and contributes to strategic decisions. His experience in the biotechnology sector is valuable for the development of Alzamend Neuro. As a board member, he ensures that the company meets its objectives and fulfills its commitments to customers and partners.